Neptune Technologies & Bioressources Inc  

(Public, TSE:NTB)   Watch this stock  
Find more results for NTB
1.63
+0.02 (1.24%)
Jun 1 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.56 - 1.63
52 week 1.26 - 3.15
Open 1.56
Vol. 29,418.00
Mkt cap 121.32M
P/E     -
Div/yield     -
EPS -0.25
Shares 75.35M
Beta 1.90
Inst. own     -
May 28, 2015
Q4 2015 Neptune Technologies & Bioressources Inc Earnings Call - Webcast
May 27, 2015
Q4 2015 Neptune Technologies & Bioressources Inc Earnings Release
Apr 30, 2015
Neptune Technologies & Bioressources Inc Conference Call to Discuss Business Updates
Mar 10, 2015
Neptune Technologies & Bioressources Inc at ROTH Conference
  

Key stats and ratios

Q4 (Nov '14) 2014
Net profit margin 1.56% -114.06%
Operating margin -123.13% -112.41%
EBITD margin - -103.69%
Return on average assets 0.26% -26.21%
Return on average equity -7.96% -31.30%
Employees 111 -
CDP Score - -

Address

545 Prom du Centropolis Suite 100
LAVAL, QC H7T 0A3
Canada
+1-450-6872262 (Phone)
+1-450-6872272 (Fax)

Website links

Description

Neptune Technologies & Bioressources Inc. (Neptune) is a Canada-based biotechnology company. The Company is engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The Company operates in three segments: Neptune, Acasti Pharma Inc. and NeuroBioPharmInc. The Neptune segment produces and commercializes nutraceutical products. The Company’s Acasti Pharma Inc. develops and commercializes pharmaceutical applications for cardiovascular diseases. The Company’s NeuroBioPharm Inc. develops and commercializes pharmaceutical applications for neurological diseases. The Company’s products include Neptune Krill Oil (NKO) and ECOKRILL Oil (EKO) which come in capsule form and serve as a dietary supplement to consumers.

Officers and directors

Pierre Fitzgibbon Chairman of the Board
Age: 60
James Stuart Hamilton President, Chief Executive Officer, Director
Andre Godin Chief Financial Officer
Michel Timperio Senior Vice President of Sales - Global Sales
Wael Massrieh Vice President - Scientific Affairs
Fotini Sampalis M.D., Ph.D. Chief Global Strategy Officer
Ronald Denis Director
Harlan W. Waksal M.D. Director
Age: 60
Valier Boivin Independent Director
Adrian Montgomery Independent Director